Le Lézard
Classified in: Health
Subjects: TDS, TRI

LSO Medical to Unveil SnakeBack® Technology at MEDICA 2017


PARIS, November 13, 2017 /PRNewswire/ --

LSO Medical announced today plans to unveil their newly engineered endovenous therapy technology SnakeBack® at the 2017 MEDICA show in Dusseldorf Nov. 13-Nov. 17 (Hall 10, B74). Show attendees will be the first to see prototype of the Plug&Treat OR designed system SnakeBack®, to perfectly standardize and automatize endovenous energy delivery.

Endovenous Treatment for the elimination of unhealthy varicose veins has become the gold-standard for minimally invasive treatment of varicose vein, with now hundreds thousands procedures performed in the world every year. Laser and radiofrequency catheters with manual operation are commonly used during this procedure.

In order to make the laser procedures simpler, LSO Medical focused its R&D efforts in ergonomy and standardization of current endovenous procedure, with objective to "freeing" physician from withdrawals. Thanks to its unique conception, the SnakeBack® technology ensures an automatic removal of the catheter, without the need for catheter tension or device alignment with the leg to be treated. The patented technology SnakeBack device appears as the next generation of the actual pull-back devices, bypassing their constraints.

"We took a big step forward with SnakeBack® in terms of procedure standardization and ergonomicsSnakeBack. A key objective for showing our new technology at MEDICA is to gauge industry interest in this concept as we are working to commercialize new devices with such technology next year," said Philippe ROCHON, President, LSO medical.

About LSO Medical 

With more than 15 years' experience, LSO Medical has become a key player in the design, production and marketing of medical laser systems.

Constantly aiming at exploiting and bringing technological innovations to doctors and their patients, LSO Medical is today one of the world leaders in the endothermic laser technique.

Contact 

To learn more about the SnakeBack technology : [email protected]


These press releases may also interest you

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...

at 02:54
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...

at 02:50
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...



News published on and distributed by: